Filter
355
Text search:
National
Pharmacovigilance
Policy
Featured
Recommendations
38
New Publications
110
Language
Document type
No document type
184
Guidelines
60
Studies & Reports
45
Strategic & Response Plan
27
Manuals
23
Training Material
6
Fact sheets
6
Situation Updates
3
Infographics
1
Countries / Regions
Kenya
19
Uganda
15
Global
15
India
14
Ghana
13
Western and Central Europe
13
Nigeria
12
Eastern Europe
11
Namibia
10
Nepal
9
South Africa
9
Ethiopia
8
Rwanda
8
Sierra Leone
6
Malawi
6
Zambia
5
Tanzania
5
South–East Asia Region
5
Liberia
4
Congo, Democratic Republic of
4
Cambodia
4
Bangladesh
4
West and Central Africa
4
Zimbabwe
3
Lesotho
3
East and Southern Africa
3
Latin America and the Carribbean
3
Russia
3
Senegal
2
Philippines
2
Syria
2
Indonesia
2
Mozambique
2
Sudan
2
Benin
2
Eswatini/ Swaziland
2
Ukraine
2
Botswana
2
Madagascar
2
Myanmar / Burma
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Asia
2
Africa
2
Cameroon
1
Haiti
1
Pakistan
1
Jordan
1
Afghanistan
1
Lebanon
1
Thailand
1
Gambia
1
Central African Republic
1
Libya
1
Sri Lanka
1
Yemen
1
Western Pacific Region
1
Bhutan
1
Laos
1
Georgia
1
Vietnam
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
174
Clinical Guidelines
42
Public Health
9
Women & Child Health
6
Capacity Building
5
Key Resources
5
Pharmacy & Technologies
5
Toolboxes
TB
43
Pharmacy
37
AMR
29
Malaria
25
COVID-19
22
HIV
18
NTDs
16
NCDs
5
Ebola & Marburg
3
Refugee
2
Specific Hazards
2
Caregiver
2
Cholera
1
Polio
1
Rapid Response
1
Global Health Education
1
Planetary Health
1
2.0 Rapid Response
1
This is a translation of the original French document titled: "POLITIQUE NATIONALE
DE PHARMACOVIGILANCE A MADAGASCAR"
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe
...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 37.
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwa
...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to
...
National Medicines Policy 2015
recommended
Apart from implementation of TB infection Prevention and Control measures, treatment of those with active TB of the lungs is key in preventing the spread of the TB bacilli. The Public Health Act CAP 242, section 17 classify TB as notifiable infectious disease and under section 26 as part of preventi
...
Therapeutics Information and Pharmacovigilance Centre | TIPC
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This
...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities
...
